THC
52
9
AAPL
64
3
WHR
61
3
INTC
35
4
SJM
17
5
FOX
71
3
EA
41
3
INTU
54
2
VIX
41
-11
VRSK
54
2
NEE
39
9
FTI
61
5
SIG
52
5
DFS
64
4
PLD
35
5
BAC
38
3
XEL
48
11
PWR
63
3
EBAY
42
2
AMT
30
2
THC
52
9
AAPL
64
3
WHR
61
3
INTC
35
4
SJM
17
5
FOX
71
3
EA
41
3
INTU
54
2
VIX
41
-11
VRSK
54
2
NEE
39
9
FTI
61
5
SIG
52
5
DFS
64
4
PLD
35
5
BAC
38
3
XEL
48
11
PWR
63
3
EBAY
42
2
AMT
30
2
Financhill
Back

CRISPR Therapeutics AG Vs. NLS Pharmaceutics Industry Stock Comparison

Sell
28

CRSP
CRISPR Therapeutics AG

Last Price:
$40.74
Seasonality Move:
16.92%
Sell
28

NLSP
NLS Pharmaceutics

Last Price:
$1.91
Seasonality Move:
0.34%
Sell
28
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $40.72. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NLS Pharmaceutics (NLSP) is a Sell

Is NLS Pharmaceutics a Buy, Sell or Hold?

  • The current NLS Pharmaceutics [NLSP] share price is $1.92. The Score for NLSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $40.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NLSP Stock Price Chart

What is NLS Pharmaceutics's stock price today?

  • The NLS Pharmaceutics share price today is $1.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.05 Sell
Relative Strength Index (14 RSI): 33.92 Sell
Chaikin Money Flow: 1963017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.97 - 51.27) Sell
Bollinger Bands (100): (45.2 - 50.74) Sell

NLSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 33.75 Sell
Chaikin Money Flow: -115060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.01 - 3.29) Sell
Bollinger Bands (100): (3.09 - 6.53) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.5 Sell
20-day SMA: 47.77 Sell
50-day SMA: 48.31 Sell
200-day SMA: 53.99 Sell
8-day EMA: 43.38 Sell
20-day EMA: 46.13 Sell
50-day EMA: 47.73 Sell
200-day EMA: 52.28 Sell

NLSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.99 Sell
20-day SMA: 2.5 Sell
50-day SMA: 3.46 Sell
200-day SMA: 5.95 Sell
8-day EMA: 2.07 Sell
20-day EMA: 2.44 Sell
50-day EMA: 3.34 Sell
200-day EMA: 8.07 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.20 per share, and an increase next year of $0.14 per share.

NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NLS Pharmaceutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):